Article
GATA2 deficiency and MDS / AML : Experimental strategies for disease modelling and future therapeutic prospects
26 Jun 2022
Abstract excerpt
The importance of predisposition to leukaemia in clinical practice is being increasingly recognized. This is emphasized by the establishment of a novel WHO disease category in 2016 called "myeloid neoplasms with germline predisposition". A major syndrome within this group is GATA2 deficiency, a heterogeneous immunodeficiency syndrome with a very high lifetime risk to develop myelodysplastic syndrome (MDS) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
